DoD Prostate Cancer Idea Development Award

The summary for the DoD Prostate Cancer Idea Development Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.

DoD Prostate Cancer Idea Development Award: The PCRP Idea Development Award mechanism was introduced in FY97. Since then, 4,330 proposals have been received and 831 have been recommended for funding. The Idea Development Award supports innovative, high-risk/high-gain approaches to prostate cancer research. The PCRP seeks proposals from all areas of basic, preclinical, behavioral, and epidemiological research. NEW FOR FY08: Clinical trials are not acceptable under this mechanism. PIs wishing to apply for funding for a clinical trial should utilize the Clinical Trial Award mechanism. Important aspects of the Idea Development Award are as follows: 1. Innovation: Innovative research may represent a new paradigm, challenge existing paradigms, or look at existing problems from new perspectives. It is the responsibility of the PI to clearly and explicitly articulate how the proposed research is innovative. Research that is an incremental advance upon published data is not considered innovative and will not be considered for funding under this mechanism. 2. Impact: Research that has high impact will, if successful, significantly advance current methods and concepts for the prevention, detection, diagnosis, or treatment of human prostate cancer. It is the responsibility of the PI to clearly and explicitly articulate the potential impact the proposed research will have on human prostate cancer. 3. Preliminary Data: NEW FOR FY08: Submission of preliminary data relevant to prostate cancer and the proposed project is encouraged but not required. Although groundbreaking research often involves a degree of risk due to unforeseen difficulties or results, these proposals should be based on a sound scientific rationale that is established through logical reasoning and/or critical review and analysis of the literature.